Cardiovascular Diseases
3,001
373
521
1,825
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
199 trials with published results (7%)
Research Maturity
1825 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.7%
82 terminated out of 3001 trials
95.7%
+9.2% vs benchmark
10%
298 trials in Phase 3/4
11%
199 of 1825 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1825 completed trials
Clinical Trials (3001)
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
The TRICURE EU Pivotal Study
A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)
Ketogenic Diet in Healthy Adults With Differing BMI
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
The TRICURE EFS Study
SPYRAL GEMINI Pilot Study
Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
Validity and Reliability of the Turkish Version of the Cardiac Depression Scale
Association Between Cardiovascular Diseases and Mental Illness
The PulsePoint Study
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Mortality Outcome of Controlled Hypertension
Dachundou No Sugar Added Soymilk for Lipid Modulation
A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities
Spyral InSight Study
Global Paradise System US Post Approval Study
Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery